Behavioral Functioning and Treatment Adherence in Pediatric Inflammatory Bowel Disease: Review and Recommendations

Kevin A Hommel1, Lee A Denson, Wallace V Crandall

  • 1Assistant Professor of Pediatrics in the Division of Behavioral Medicine and Clinical Psychology at the University of Cincinnati College of Medicine and is affiliated with the Center for the Promotion of Treatment Adherence and Self-Management at the Cincinnati Children's Hospital Medical Center, both in Cincinnati, Ohio.

Insights

Behavioral issues in pediatric inflammatory bowel disease (IBD) can negatively impact treatment adherence. This review offers clinical recommendations for assessing and managing behavioral challenges in children and adolescents with IBD.

Area of Science:

  • Pediatric Gastroenterology
  • Child and Adolescent Psychiatry
  • Behavioral Medicine

Background:

  • Inflammatory bowel disease (IBD) presents unique challenges for pediatric patients and their families.
  • Behavioral functioning is increasingly recognized as a critical factor in managing chronic illnesses.

Purpose of the Study:

  • To review research on behavioral functioning and treatment adherence in pediatric IBD.
  • To explore how behavioral dysfunction affects adherence to IBD treatments.
  • To provide clinical recommendations for assessment and management strategies.

Main Methods:

  • An updated literature review focusing on pediatric IBD was conducted.
  • Existing research across various chronic conditions was analyzed for relevant insights.
  • Evidence regarding the impact of behavioral problems on disease management was synthesized.

Main Results:

  • Behavioral problems in patients and families can adversely affect disease management in pediatric IBD.
  • A strong link exists between behavioral dysfunction and suboptimal treatment adherence.
  • Multimethod assessment and routine screening are crucial for identifying behavioral difficulties.

Conclusions:

  • Early identification and intervention for behavioral issues are essential for improving treatment adherence in pediatric IBD.
  • Clinical strategies should include open communication between patients, families, and providers.
  • Transitioning disease management responsibility from parents to adolescents requires careful attention.

Related Concept Videos

Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...